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AbstrACt
background An immunochromatographic rapid test 
(ICT; Schistosoma ICT IgG-IgM, LDBIO Diagnostics) 
demonstrated high sensitivity (96%) in the diagnosis of 
Schistosoma mansoni  and S. haematobium. To date, the 
test has been validated for use on serum only, but in the 
absence of lab equipment, blood drop from fingerprick 
could be a useful option. This method is acquiring more 
interest because of the high flow of migrants rapidly 
moving across Italy and other European countries.
Objective The aim of this prospective study was to 
evaluate the use of ICT on whole blood obtained from 
fingerprick.
setting Centre for Tropical Diseases (CTD), Sacro Cuore 
Don Calabria Hospital, Negrar, Verona, Italy.
Participants The inclusion criteria were African migrants 
aged ≥18 years with epidemiological risk of infection. 
The exclusion criteria were refusal to participate in the 
study and impossibility of execution of one of the two 
study methods, for any reason. Seventy of the 72 eligible 
patients completed the study, 79% of whom were male.
Interventions The ICT was performed twice for each 
included patient: one on blood drop (by the research 
nurses, in the ward) and one on serum (by staff of CTD 
lab). The primary outcome was the concordance between 
the two methods, assessed by Cohen’s kappa.
results Cohen’s kappa was 0.45 (95% CI 27.0 to 63.6), 
indicating moderate agreement between the ICT on serum 
and the ICT on blood drop. Assuming the results on serum 
as reference standard for diagnosis, the sensitivity and 
specificity of ICT on blood drop were 55% (95% CI 40 to 
69) and 93% (95% CI 79 to 98), respectively.
Conclusions The agreement between the two diagnostic 
methods is too low to support the alternative one. 
Implementation of the kit for using blood drop instead of 
the serum and/or further studies aimed to identify easy-
to-use tests for schistosomiasis feasible outside referral 
centres for tropical diseases are needed.
bACkgrOund
Schistosomiasis is a parasitic infection caused 
by fluke worms of the genus Schistosoma. The 
main species affecting humans are Schisto-
soma mansoni, S. haematobium, S. japonicum 
and S. intercalatum. According to estimates, at 
least 200 million people are infected world-
wide, most of them in sub-Saharan Africa.1 2 
Risk estimates of infection based on geosta-
tistical modelling showed the highest preva-
lence in Mozambique (52.8% (48.7–57.8)), 
followed by Benin (36% (26.9–43.9)), Sierra 
Leone (35% (28.9–42.1)) and Mali (34.2% 
(31.3–37.1)).3 
Most of the reported infections are clin-
ically mild or even asymptomatic for a long 
time. However, chronic infections can lead 
to severe complications, mainly involving the 
urinary tract (haematuria, hydronephrosis, 
squamous bladder cancer) and the gastro-
intestinal tract (mucosal granulomatous 
inflammation, pseudopolyposis, microulcer-
ation, bleeding, hepatosplenomegaly, portal 
hypertension), according to the Schistosoma 
species.4
Despite the clinical relevance of this infec-
tion, and the potentially increasing number 
of cases present in most European countries 
due to migration flows,5 schistosomiasis has 
strengths and limitations of this study
 ► This is the first study to  evaluate the use of an 
immunochromatographic rapid diagnostic test for 
schistosomiasis in African immigrants in Italy.
 ► The study highlights the need for reliable, rapid and 
easy-to-use diagnostic tests to improve access to 
diagnosis and treatment for schistosomiasis in 
immigrants coming from endemic to non-endemic 
countries.
 ► The population under study (immigrants observed 
at the hospital) might not be representative of the 
general population of African immigrants in Italy.
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been not included in national screening programmes 
targeting migrants arriving from endemic countries to 
Europe. However, some recommendations in this sense 
have been recently proposed.6 7 Authorities and health 
workers who are not used to dealing with these specific 
conditions are often simply unaware of the burden of 
this and other neglected tropical diseases. Moreover, 
control programmes tend to target infections perceived 
as a potential threat to the hosting populations, as is the 
case of tuberculosis and other communicable diseases.8 
However, the outbreak of schistosomiasis in Corsica, 
France, due to the colonisation of freshwater snails 
diffused along the Cavu Riverbank, reminded us that 
local transmission of imported parasitic infections is 
improbable but not impossible.9
The estimation of the real burden of schistosomiasis 
has been hampered by the lack of an adequate gold stan-
dard for diagnosis.1 In fact, the detection of parasites’ 
eggs in stool and urine samples using microscopic exam-
ination has low sensitivity. In turn this could underesti-
mate the prevalence of infection. Hence, several indirect 
immunological tests have been implemented. Recently, 
a diagnostic study compared various techniques for the 
immunological diagnosis of schistosomiasis, including 
western blotting, ELISA, circulating cathodic antigen 
dipstick test and an immunochromatographic (rapid) 
test (ICT).10 The latter demonstrated the highest sensi-
tivity (96%), with a negative predictive value of 98%, 
and it might be the ideal tool for screening, at least in 
non-endemic settings. Other immunological rapid tests 
for different parasitic infections (mostly for malaria11) 
have been implemented for use with a blood drop from 
fingerprick, so that they can be performed in the field. In 
consideration of the constantly increasing migration flows 
from the poorest countries to Europe, sensitive screening 
tests that could also be used in the absence of minimal 
lab equipment (such as a centrifuge), such as primary 
healthcare centres for migrants, are appealing. Moreover, 
fingerprick instead of venipuncture would minimise the 
biological risk for the staff performing the test, besides 
being more acceptable for the migrants.
Objective
The aim of this study was to compare the results of 
the Schistosoma ICT IgG-IgM (LDBIO Diagnostics) 
performed on blood drops obtained from fingerprick 
with the ones obtained from the same test performed 
following the standard procedures and using the serum 
from venipuncture as the substrate.
MethOds
We performed a prospective study. Eligible patients were 
included once they gave their (written) informed consent.
setting and participants
Eligible participants were all male or female African 
immigrants admitted for any cause to the ward of the 
Centre for Tropical Diseases (CTD) in Negrar from 3 
April 2017 to 2 August 2017. Other inclusion criteria 
were age ≥18 years and exposure to epidemiological risk 
of infection (living in endemic areas, bathing in fresh-
water). Exclusion criteria were refusal to participate in 
the study and impossibility of execution of one of the two 
study methods, for any reason.
Interventions
A research nurse collected the blood samples from each 
patient included in the study, through venipuncture as 
well as through fingerprick. The two procedures were 
performed on the same day.
Procedures for the test on serum
Instructions for use were given by the manufacturer.12 
The blood sample was collected in an EDTA tube, 
labelled with the patient’s code and then sent to the CTD 
lab. Once there, the sample was centrifuged and 30 µL of 
the obtained serum was added with a pipette to the ICT 
cassette, followed by two drops of eluent (supplied with 
the kit). The result was read between 20 and 30 min after 
the execution. Tests without appearance of the control 
band were considered uncorrected and then repeated. A 
positive test was defined by the appearance of a coloured 
band in the test field. Each result was read independently 
by two lab technicians, who were not aware of the result 
of the test performed from fingerprick on the same 
sample. In case of discordant results, a third technician 
was involved in the test reading. Each technician inde-
pendently reported the result on a paper labelled with 
the patient’s code.
Procedures for the test on blood drop
The blood obtained via fingerprick was dropped on 
the device. The research nurse performing the test and 
another investigator independently read the result and 
reported it on the case report form (CRF). They were 
both blinded towards the results obtained by the lab staff 
(who ran the test on serum in parallel). In case of discor-
dant results, a second investigator was involved in reading 
the test. The time frame for reading and interpretation 
of the results was analogous to those used for the test on 
serum. Inconclusive results (given by absent or uncom-
pleted migration of blood along the strip) were registered 
as such.
The principal investigator collected all CRFs, matched 
the information with the results obtained by the lab staff 
and entered all required data (including country of 
origin, date of birth, sex, date of execution from the test), 
anonymously, in a database (Excel file).
Analysis
The concordance among the results of the two procedures 
was assessed using Cohen’s kappa coefficient. The results 
of Cohen’s kappa were interpreted as follows: poor agree-
ment=less than 0.20; fair agreement=0.20–0.40; moderate 
agreement=0.40–0.60; good agreement=0.60–0.80; 
and very good agreement=0.80–1.00.
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The expected prevalence of schistosomiasis in the study 
population was estimated at around 38%,5 according to 
a recent study. The sample size was calculated using the 
‘R Studio’ software (Open Source Ed), considering an 
alpha ≤0.05, study power ≥80% and a one-sided test. The 
number of patients to be included in the study was 69.
results
All eligible patients agreed to take part in the study. The 
study flow is presented in figure 1. The median age of partic-
ipants was 24 years (IQR: 20.5–30.5), and 57/72 (79%) 
eligible patients were male. Countries of origin are reported 
in table 1.
In two cases (one patient from Mali and one from Côte 
d’Ivoire), the fingerprick test gave an inconclusive result 
(incomplete blood migration), while the corresponding 
tests on serum were positive. These two patients were even-
tually excluded from the analysis; hence, 70 patients were 
included.
A third reader was required twice for the ICT performed 
in the lab and three times for the test performed via blood 
spot. In all cases, the reason for involving a third reader was 
the presence of a very weak positive band; the final result 
was given as positive in all cases.
Table 2 shows the results of the ICT performed with the 
two methods.
Discordant results were 20 out of 70 (28.6%), mainly due 
to negative ‘fingerprick’ tests that were positive on serum 
(18 cases) instead. Cohen’s kappa was 0.45 (95% CI 27.0 to 
63.6), indicating moderate agreement. Assuming the results 
on serum as the reference standard, the sensitivity and spec-
ificity of ICT on blood drop were 55% (95% CI 40 to 69) 
and 93% (95% CI 79 to 98), respectively. Four patients were 
HIV-positive. Two patients had discordant results, with one 
of them resulting positive on the test on serum and negative 
on the fingerprick test, and vice versa in the second case.
dIsCussIOn
The test performed on serum identified more positive 
patients than the same test performed on blood drop. 
As a result, the alternative method showed low sensitivity, 
when compared with the validated method. This might be 
Figure 1 Study flow chart.
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due to the composition of the nitrocellulose strip, which 
may not allow a proper flow of the blood drop and/or 
the development of the antibodies/antigen bond might 
be altered in the presence of proteins present in whole 
blood. However, it must be considered that, according 
to our previous diagnostic study,10 the specificity of ICT 
on serum is not as high as the sensitivity (around 80%). 
Hence, an additional explanation for the lower number of 
positive results obtained by fingerprick might be that this 
method produces less false-positive results. Moreover, the 
prevalence of schistosomiasis was similar to the expected 
one (38%) when evaluated with the test performed via 
fingerprick (34.3%), while it was extremely high (57.1%) 
when considering the test on serum. Although this might 
support the possible higher specificity of the test on 
blood drop, it might also be caused by a relatively high 
proportion of patients who were admitted to the CTD 
ward for symptoms/complications due to schistosomiasis 
(however, this information was not specifically collected 
in this study). In any case, based on the results of this 
study, the performance of the two methods differed too 
much to support the use of fingerprick test. Moreover, it 
must be considered that two patients had to be excluded 
for inconclusive results, and in three cases a third reader 
was involved, meaning that the test was not of easy inter-
pretation. Further evaluation, including more diagnostic 
assays for schistosomiasis, is required to clarify our find-
ings. In the meantime, the manufacturer communicated 
with us the intention to modify the nitrocellulose strip 
in order to improve its use with blood drops. In the last 
years, an increasing number of migrants from Africa 
has accessed our centre for screening and diagnosis of 
different parasitic infections. Many of them are only 
temporarily present in Verona province, and it is often 
difficult to plan follow-up visits. This scenario is common 
in many other places in Italy. Pending cost-effective-
ness studies defining whether it might be worth, in our 
setting, to administer empirical antiparasitic treatments 
according to the area of origin of migrants, we need to 
identify diagnostic tools that can produce rapid, reliable 
results.
The treatment for schistosomiasis is short term and well 
tolerated4; hence, it might be worth treating individuals 
with positive results on a screening test, even in the absence 
of a second, more specific exam. This could represent a first 
step towards an improved access to the diagnosis and treat-
ment of schistosomiasis in migrant populations.
study limitations
ICT has not been extensively evaluated in the literature; 
hence, further diagnostic studies are needed to confirm 
our previous findings.10 Additionally, we did not assess 
the influence of different volumes of whole blood on the 
accuracy of the test used via fingerprick, because our aim 
was to reproduce the field conditions. The small number 
of patients included in each geographical subset did not 
permit exploration of a possible association between 
discrepant results and the country of origin. Further, 
we could not analyse the possible relationship between 
the results of the tests and previous treatment with prazi-
quantel, as the latter data were not available. Finally, 
another limitation is related to the study population. It 
was composed of patients admitted to the hospital; hence, 
they might not be representative of the general popula-
tion of African immigrants present in Italy.
COnClusIOns
The use of ICT test on blood drop from fingerprick did not 
demonstrate an adequate concordance with the validated 
method (test on serum). Implementation of the same kit 
using blood drop as the substrate and/or further studies 
aimed to identify tests for schistosomiasis feasible to be 
performed outside referral centres for tropical diseases are 
needed.
Table 1 Countries of origin of the eligible patients
Country Patients included, n (%)
Western Africa
  Burkina Faso 1 (1.4)
  Gambia 2 (2.8)
  Ghana 9 (12.5)
  Guinea 3 (4.2)
  Guinea Bissau 5 (6.9)
  Guinea 1 (1.4)
  Côte d’Ivoire 14 (19.4)
  Liberia 1 (1.4)
  Mali 8 (11.1)
  Nigeria 8 (11.1)
  Senegal 7 (9.7)
  Sierra Leone 1 (1.4)
  Togo 1 (1.4)
Eastern Africa
  Eritrea 3 (4.2)
  Sudan 1 (1.4)
Central Africa
  Angola 5 (6.9)
  Cameroon 2 (2.8)
  Total 72 (100)
Table 2 Results of the immunochromatographic rapid test 
performed with the two methods
Test on whole blood
Test on serum
TotalNegative Positive
Negative 28 18 46
Positive 2 22 24
Total 30 40 70
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